MARKET

BBNX

BBNX

Beta Bionics, Inc.
NASDAQ
17.00
+0.18
+1.07%
After Hours: 17.00 0 0.00% 17:29 06/29 EDT
OPEN
16.83
PREV CLOSE
16.82
HIGH
17.18
LOW
16.69
VOLUME
715.56K
TURNOVER
--
52 WEEK HIGH
32.71
52 WEEK LOW
8.80
MARKET CAP
757.55M
P/E (TTM)
-11.2471
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BBNX last week (0622-0626)?
Weekly Report · 18h ago
Beta Bionics director Christy Jones sells 1,406 shares for $21,090
PUBT · 4d ago
Analysts Offer Insights on Healthcare Companies: Compugen (CGEN), Beta Bionics, Inc. (BBNX) and Argenx Se (ARGX)
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Regeneron (REGN) and Alkermes (ALKS)
TipRanks · 06/22 11:06
Weekly Report: what happened at BBNX last week (0615-0619)?
Weekly Report · 06/22 09:35
Weekly Report: what happened at BBNX last week (0608-0612)?
Weekly Report · 06/15 09:36
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
Barchart · 06/15 09:25
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth
PR Newswire · 06/12 16:50
More
About BBNX
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.

Webull offers Beta Bionics, Inc. stock information, including NASDAQ: BBNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BBNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BBNX stock methods without spending real money on the virtual paper trading platform.